Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

3(37.5%)

N/A

3(37.5%)

Phase 2

2(25.0%)

8Total

Phase 1(3)

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05610878Phase 1Recruiting

Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting

Role: collaborator

NCT05610865Phase 1Recruiting

Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers

Role: collaborator

NCT04891172Phase 2Unknown

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Role: collaborator

NCT04521309Phase 1Completed

SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients

Role: collaborator

NCT03343366Phase 2Completed

Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy

Role: collaborator

NCT04299568Not ApplicableCompleted

Effects of Anti-gravity Treadmill Training on Knee Osteoarthritis in Geriatric Population.

Role: collaborator

NCT04222049Not ApplicableCompleted

Application of Vibration Wave Therapy to the Children Suffering From Cerebral Palsy and Tongue Spastic Dysarthria

Role: collaborator

NCT01201746Not ApplicableCompleted

Influence of Periodontal Treatment on Systemic Inflammatory Mediators

Role: collaborator

All 8 trials loaded